Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000868555 | SCV000395377 | uncertain significance | Aortic aneurysm, familial thoracic 4 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Color Diagnostics, |
RCV000404122 | SCV000913644 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-05-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000868555 | SCV001009896 | likely benign | Aortic aneurysm, familial thoracic 4 | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001797705 | SCV002041611 | likely benign | not specified | 2021-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001572649 | SCV002056032 | uncertain significance | not provided | 2022-01-04 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported in ClinVar (ClinVar Variant ID#318169) |
Ambry Genetics | RCV000404122 | SCV002721135 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2019-11-01 | criteria provided, single submitter | clinical testing | The p.G627S variant (also known as c.1879G>A), located in coding exon 15 of the MYH11 gene, results from a G to A substitution at nucleotide position 1879. The glycine at codon 627 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Laboratory of Diagnostic Genome Analysis, |
RCV001572649 | SCV001797342 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001572649 | SCV001963711 | uncertain significance | not provided | no assertion criteria provided | clinical testing |